Tumor inhibition by metallocenes: activity against leukemias and detection of the systemic effect.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D007939:Leukemia L1210 / Q000188:drug therapy; D007941:Leukemia P388 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy*; D051379:Mice; D008815:Mice, Inbred Strains; D009942:Organometallic Compounds / Q000627:therapeutic use*; D014025:Titanium / Q000627:therapeutic use*; D014639:Vanadium / Q000627:therapeutic use*; D017968:Vanadium Compounds
D000970:Antineoplastic Agents; D009942:Organometallic Compounds; D017968:Vanadium Compounds; D014639:Vanadium; C030754:vanadocene dichloride; D014025:Titanium; C020528:titanocene dichloride